Long-Term Outcomes of Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Secondary to Myelodysplastic Syndrome
| Autor: | Potter, Victoria T., Krishnamurthy, Pramila, Barber, Linda D., Lim, ZiYi, Kenyon, Michelle, Ireland, Robin M., de Lavallade, Hugues, Dhouri, Abdel, Marsh, Judith C.W., Marcus, Robert, Devereux, Stephen, Ho, Aloysius, Pagliuca, Antonio, Mufti, Ghulam J. |
|---|---|
| Zdroj: | In Biology of Blood and Marrow Transplantation January 2014 20(1):111-117 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect